论文部分内容阅读
胎儿及胎盘蛋白质的生化检测,已用于评价早孕并发症患者妊娠后果。测定绒毛膜促性腺激素(HCG)及胎盘生乳素(HPL)预测孕儿存活率已有报告。作者最近测定145例妊娠6～12周发生大量阴道流血患学的妊娠特种β糖白(Pregnancy Specificβ—glycoprotien SP_1)。证明 SP_1水平降低预测妊娠后果不佳的特异性达98%,预测价值96%。其意义至少与测 HCG 及 HP_1相似,甚至与超声检查有同样实用价值。145例住院早孕并发症孕妇,经超声探查分为胎儿存活、孕卵萎缩及不完全流产。异
Biochemical tests of fetal and placental proteins have been used to assess the pregnancy outcome in early pregnancy complications. Determination of chorionic gonadotropin (HCG) and placental lactogen (HPL) to predict the survival of pregnant children have been reported. The authors have recently determined that Pregnancy Specific β-glycoprotien SP-1 in 145 cases of vaginal bleeding during 6-12 weeks of gestation. Demonstrate that the lower SP_1 level predicts poor outcomes in pregnancy with a specificity of 98% and a predictive value of 96%. Its meaning is at least as good as HCG and HP_1, even with the same practical value as ultrasound. 145 cases of pregnant women with early pregnancy complications were divided into fetal survival by ultrasound, pregnancy atrophy and incomplete abortion. different